Tharimmune, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
4.950
+0.210 (4.43%)
At close: Feb 18, 2026, 4:00 PM EST
4.910
-0.040 (-0.81%)
Pre-market: Feb 19, 2026, 6:16 AM EST
Company Description
Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets.
It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023.
Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.
Tharimmune, Inc.
| Country | United States |
| Founded | 2017 |
| Employees | 3 |
| CEO | Mark Wendland |
Contact Details
Address: 34 Shrewsbury Avenue, Suite 1C Red Bank, New Jersey 07701 United States | |
| Phone | 732 889 3111 |
| Website | tharimmune.com |
Stock Details
| Ticker Symbol | CNTN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
Key Executives
| Name | Position |
|---|---|
| Mark Wendland | Chief Executive Officer |
| Jacob Asbury | Chief Financial Officer |
| Angela Radkowski | Chief Operating Officer |